{"id":"https://openalex.org/W4392680185","doi":"https://doi.org/10.1158/0008-5472.c.6503508","title":"Data from MiR-96 Downregulates REV1 and RAD51 to Promote Cellular Sensitivity to Cisplatin and PARP Inhibition","display_name":"Data from MiR-96 Downregulates REV1 and RAD51 to Promote Cellular Sensitivity to Cisplatin and PARP Inhibition","publication_year":2023,"publication_date":"2023-03-30","ids":{"openalex":"https://openalex.org/W4392680185","doi":"https://doi.org/10.1158/0008-5472.c.6503508"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.c.6503508","doi":"https://doi.org/10.1158/0008-5472.c.6503508","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6503508","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/0008-5472.c.6503508","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087622468","display_name":"Yemin Wang","orcid":"https://orcid.org/0000-0002-2970-9510","observed_orcids":["https://orcid.org/0000-0002-2970-9510"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yemin Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042132774","display_name":"Jen\u2010Wei Huang","orcid":"https://orcid.org/0000-0001-8345-1656","observed_orcids":["https://orcid.org/0000-0001-8345-1656"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jen-Wei Huang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003373949","display_name":"Philamer C. Calses","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philamer Calses","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112265164","display_name":"Christopher J. Kemp","orcid":"https://orcid.org/0000-0001-7238-8452","observed_orcids":["https://orcid.org/0000-0001-7238-8452"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher J. Kemp","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5036540850","display_name":"Toshiyasu Taniguchi","orcid":"https://orcid.org/0000-0002-7746-3658","observed_orcids":["https://orcid.org/0000-0002-7746-3658"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Toshiyasu Taniguchi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10062","display_name":"MicroRNA in disease regulation","score":0.6377000212669373,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10062","display_name":"MicroRNA in disease regulation","score":0.6377000212669373,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.32420000433921814,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.012900000438094139,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mir-96","display_name":"miR-96","score":0.9980000257492065},{"id":"https://openalex.org/keywords/rad51","display_name":"RAD51","score":0.8519999980926514},{"id":"https://openalex.org/keywords/rev1","display_name":"Rev1","score":0.9869999885559082},{"id":"https://openalex.org/keywords/cisplatin-sensitivity","display_name":"cisplatin sensitivity","score":0.8399999737739563},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.6809999942779541},{"id":"https://openalex.org/keywords/olaparib","display_name":"olaparib","score":0.9860000014305115},{"id":"https://openalex.org/keywords/dna-repair","display_name":"DNA repair","score":0.7680000066757202},{"id":"https://openalex.org/keywords/homologous-recombination","display_name":"homologous recombination","score":0.9869999885559082},{"id":"https://openalex.org/keywords/translesion-synthesis","display_name":"translesion synthesis","score":0.8989999890327454},{"id":"https://openalex.org/keywords/interstrand-crosslinks","display_name":"interstrand cross-links","score":0.7950000166893005},{"id":"https://openalex.org/keywords/chemosensitivity","display_name":"chemosensitivity","score":0.8569999933242798},{"id":"https://openalex.org/keywords/microrna-target-regulation","display_name":"microRNA target regulation","score":0.6959999799728394},{"id":"https://openalex.org/keywords/3-untranslated-region","display_name":"3' untranslated region","score":0.7910000085830688},{"id":"https://openalex.org/keywords/cancer-therapy","display_name":"cancer therapy","score":0.3930000066757202}],"concepts":[{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.7976307272911072},{"id":"https://openalex.org/C2779138821","wikidata":"https://www.wikidata.org/wiki/Q7118227","display_name":"PARP inhibitor","level":5,"score":0.7149569988250732},{"id":"https://openalex.org/C2779012473","wikidata":"https://www.wikidata.org/wiki/Q3235015","display_name":"RAD51","level":4,"score":0.689638614654541},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.6589505076408386},{"id":"https://openalex.org/C21200559","wikidata":"https://www.wikidata.org/wiki/Q7451068","display_name":"Sensitivity (control systems)","level":2,"score":0.5722165107727051},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5215209126472473},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.38997048139572144},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3341560363769531},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.2828209698200226},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1915815770626068},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1668390929698944},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.13674575090408325},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.13031262159347534},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1167362630367279},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0799136757850647},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.07861137390136719},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.07299220561981201},{"id":"https://openalex.org/C24326235","wikidata":"https://www.wikidata.org/wiki/Q126095","display_name":"Electronic engineering","level":1,"score":0.047753363847732544}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.c.6503508","doi":"https://doi.org/10.1158/0008-5472.c.6503508","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6503508","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.c.6503508","doi":"https://doi.org/10.1158/0008-5472.c.6503508","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6503508","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2106671241","https://openalex.org/W4362545268","https://openalex.org/W2171039798","https://openalex.org/W2007138966","https://openalex.org/W3049509523","https://openalex.org/W2387051679","https://openalex.org/W2469684354","https://openalex.org/W2118549314","https://openalex.org/W7099636288","https://openalex.org/W7100200513"],"abstract_inverted_index":{"Abstract":[0],"Cell":[1],"survival":[2],"after":[3],"DNA":[4,8,18,26,34,70,122,148],"damage":[5],"relies":[6],"on":[7],"repair,":[9],"the":[10,23,55,63,75,81,90,99,142],"abrogation":[11],"of":[12,48,57,78,84,87,92,144],"which":[13],"causes":[14],"genomic":[15],"instability.":[16],"The":[17],"repair":[19,123],"protein":[20],"RAD51":[21,58,79,128],"and":[22,59,61,80,95,105,111,124,129],"trans-lesion":[24],"synthesis":[25],"polymerase":[27],"REV1":[28,60],"are":[29],"required":[30],"for":[31],"resistance":[32],"to":[33,66,98,106,147],"interstrand":[35],"cross-linking":[36],"agents":[37,67],"such":[38],"as":[39],"cisplatin.":[40],"In":[41],"this":[42],"study,":[43],"we":[44],"show":[45],"that":[46,68,119],"overexpression":[47],"miR-96":[49,88,120,135],"in":[50,103,109,112],"human":[51],"cancer":[52,145],"cells":[53,146],"reduces":[54],"levels":[56],"impacts":[62],"cellular":[64],"response":[65],"cause":[69],"damage.":[71,149],"MiR-96":[72],"directly":[73],"targeted":[74],"coding":[76],"region":[77,83],"3\u2032-untranslated":[82],"REV1.":[85,130],"Overexpression":[86],"decreased":[89],"efficiency":[91],"homologous":[93],"recombination":[94],"enhanced":[96],"sensitivity":[97,143],"PARP":[100],"inhibitor":[101],"AZD2281":[102],"vitro":[104,110],"cisplatin":[107],"both":[108],"vivo.":[113],"Taken":[114],"together,":[115],"our":[116],"findings":[117],"indicate":[118],"regulates":[121],"chemosensitivity":[125],"by":[126,140],"repressing":[127],"As":[131],"a":[132],"therapeutic":[133],"candidate,":[134],"may":[136],"improve":[137],"chemotherapeutic":[138],"efficacy":[139],"increasing":[141],"Cancer":[150],"Res;":[151],"72(16);":[152],"4037\u201346.":[153],"\u00a92012":[154],"AACR.":[155]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2024-03-13T00:00:00"}